• Home
  • Reagents
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Coronavirus Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Murine Bispecific Antibody Reagents
      • DNA/RNA Research Antibodies
      • Recombinant Isotype Controls
      • Tumor Marker Antigens
      • Recombinant Antibodies from Human Patients
      • Immunotherapy Research Antibodies
      • Research-Grade Biosimilars
      • VivopureX™ Antibodies for In Vivo Research
    • Secondary Antibodies
      • Anti-Human Immunoglobulin Antibodies
      • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
      • Other Secondary Antibodies
    • Recombinant Proteins
      • Overview
      • Veterinary IgE Fc Proteins
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Proteins
      • Recombinant Free Light Chains
  • Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization Service
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
      • Overview
      • HEXpress™ HEK Antibody Production
      • CHXpress™ CHO Antibody Production
      • FleXpress™ High-Throughput Antibody Production
  • Our Technology
    • Why go recombinant?
    • Our Recombinant Technology
    • Our Customers
      • Pharma/Biotech
      • Diagnostic Developers
      • Academic Researchers
    • Formats We Have Made
      • Non-IgG Isotypes
      • Chimeric Antibodies
      • Antibody Fragments
      • Fc Silent™ Antibodies
      • mAbsolve Fc Silencing Technology
      • Periodic Table of Antibodies
    • License Your Antibodies
    • Animal-Free Antibodies
  • About Us
    • Overview
    • Our Management Team
    • Our Sister Company
    • Testimonials & Case Studies
    • ISO Certification
    • Careers
    • Contact Us
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • External Resources
  • News & Events
    • Events
    • Blog
    • In the News
    • Newsletter
    • Publications
    • Company Resources
  • How to Order
    • Direct Order
    • Distributors
  • Contact us
  • FAQs
£0.00
0 items
  • Contact us
  • FAQs
United Kingdom (UK)
  • United States (US)
  • United Kingdom (UK)
  • Germany
  • Canada
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Gibraltar
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Monaco
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Other countries
£0.00
0 items
Menu
  • Home
  • Reagents
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Coronavirus Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Murine Bispecific Antibody Reagents
      • DNA/RNA Research Antibodies
      • Recombinant Isotype Controls
      • Tumor Marker Antigens
      • Recombinant Antibodies from Human Patients
      • Immunotherapy Research Antibodies
      • Research-Grade Biosimilars
      • VivopureX™ Antibodies for In Vivo Research
    • Secondary Antibodies
      • Anti-Human Immunoglobulin Antibodies
      • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
      • Other Secondary Antibodies
    • Recombinant Proteins
      • Overview
      • Veterinary IgE Fc Proteins
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Proteins
      • Recombinant Free Light Chains
  • Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization Service
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
      • Overview
      • HEXpress™ HEK Antibody Production
      • CHXpress™ CHO Antibody Production
      • FleXpress™ High-Throughput Antibody Production
  • Our Technology
    • Why go recombinant?
    • Our Recombinant Technology
    • Our Customers
      • Pharma/Biotech
      • Diagnostic Developers
      • Academic Researchers
    • Formats We Have Made
      • Non-IgG Isotypes
      • Chimeric Antibodies
      • Antibody Fragments
      • Fc Silent™ Antibodies
      • mAbsolve Fc Silencing Technology
      • Periodic Table of Antibodies
    • License Your Antibodies
    • Animal-Free Antibodies
  • About Us
    • Overview
    • Our Management Team
    • Our Sister Company
    • Testimonials & Case Studies
    • ISO Certification
    • Careers
    • Contact Us
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • External Resources
  • News & Events
    • Events
    • Blog
    • In the News
    • Newsletter
    • Publications
    • Company Resources
  • How to Order
    • Direct Order
    • Distributors

Home About Us

About Us

Absolute Antibody was founded in 2012 with a vision to make recombinant antibody technology accessible to all. We offer antibody sequencing, engineering and recombinant production as custom services, as well as a unique catalog of recombinant antibodies and Fc Fusion proteins, engineered into new and useful formats.

Overview

Learn about Absolute Antibody’s history, vision and recombinant antibody offerings.
Find out more

Our Management Team

Meet the employees behind our recombinant antibody technologies and rapid company growth.
Find out more

Our Sister Company

In 2018, Absolute Antibody merged with Kerafast, a Boston-based reagent company with a mission to facilitate access to unique laboratory-made research tools.
Find out more

Testimonials & Case Studies

Hear from our customers and partners about the benefits of our approach to recombinant antibody technology.
Find out more

ISO Certification

Our UK antibody manufacturing facility is certified under International Organization for Standardization (ISO) 9001:2015.
Find out more

Careers

Check out open positions and apply to join our growing team.
Find out more

Contact Us

Contact us in a variety of ways – we’d love to hear from you!
Find out more
Queen's Award For Enterprise
Subscribe to our e-newsletter
Twitter
LinkedIn

Explore this site

Primary Antibodies
  • Neuroscience
  • Anti-Allergen Antibodies
  • Anti-Coronavirus Antibodies
  • Anti-Virus Antibodies
  • Antibodies to Epitope Tags
  • Bispecific Antibody Reagents
  • DNA/RNA Research Antibodies
  • Recombinant F4/80 Clone CI:A3-1
  • Recombinant Isotype Controls
  • Tumor Marker Antigens
  • Recombinant Antibodies from Human Patients
  • Immunotherapy Research Antibodies
  • Research-Grade Biosimilars
  • VivopureX™ Antibodies for In Vivo Research
  • Other Products
Secondary Antibodies
  • Anti-Human Immunoglobulin Antibodies
  • Anti-Non-Human Primate (NHP) Immunoglobulin Antibodies
  • Other Secondary Antibodies
Recombinant Proteins
  • Veterinary IgE Fc Proteins
  • Fc Fusion Proteins
  • Immunoglobulin Fc domains (Ig Fc domains)
  • Multi-Tag Control Protein
  • Recombinant Free Light Chains

Copyright © 2023 Absolute Antibody. All rights reserved

  • Careers
  • Terms and Conditions
  • Privacy Policy

Website design by Electric Studio - Digital WordPress Agency Oxford